Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (10): 895-898    DOI: 10.19485/j.cnki.issn2096-5087.2023.10.014
  妇幼保健 本期目录 | 过刊浏览 | 高级检索 |
宁波市2018—2021年出生儿童肠道病毒71型疫苗接种情况分析
王炸亚1, 叶莉霞2, 吴锋3
1.宁波市江北区文教街道社区卫生服务中心,浙江 宁波 315000;
2.宁波市疾病预防控制中心,浙江 宁波 315010;
3.宁波市江北区疾病预防控制中心,浙江 宁波 315000
Coverage of enterovirus 71 vaccine among children born between 2018 and 2021 in Ningbo City
WANG Zhaya1, YE Lixia2, WU Feng3
1. Wenjiao Street Community Health Service Center, Jiangbei District, Ningbo, Zhejiang 315000, China;
2. Ningbo Center for Disease Control and Prevention, Ningbo, Zhejiang 315010, China;
3. Jiangbei District Center for Disease Control and Prevention, Ningbo, Zhejiang 315000, China
全文: PDF(738 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解浙江省宁波市2018—2021年出生儿童肠道病毒71型(EV71)疫苗接种情况,为制定EV71疫苗接种策略提供依据。方法 通过浙江省预防接种管理系统收集宁波市2018—2021年出生儿童的人口学资料和EV71疫苗接种资料,分析EV71疫苗接种率、全程接种率和及时接种率。结果 宁波市2018—2021年共出生416 176人,其中男童216 977人,占52.14%;女童199 199人,占47.86%。EV71疫苗接种率为61.50%,全程接种率为58.70%,及时接种率为32.53%。常住儿童EV71疫苗接种率、全程接种率和及时接种率分别为71.43%、70.04%和40.24%,高于流动儿童的54.05%、50.18%和26.73%(均P<0.05)。城区儿童EV71疫苗接种率、全程接种率和及时接种率分别为67.72%、65.06%和40.37%,高于郊县儿童的54.11%、51.14%和23.21%(均P<0.05)。2018—2021年出生儿童EV71疫苗接种率分别为54.98%、61.24%、65.10%和66.72%,全程接种率分别为52.16%、58.72%、62.44%和63.39%,及时接种率分别为22.47%、25.86%、39.14%和48.03%,均呈上升趋势(均P<0.05)。结论 宁波市2018—2021年出生儿童EV71疫苗接种率、全程接种率和及时接种率均呈上升趋势,但及时接种率仍较低,需针对郊县、流动儿童加强EV71疫苗接种宣传。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
王炸亚
叶莉霞
吴锋
关键词 肠道病毒71型疫苗手足口病预防接种    
AbstractObjective To investigate the coverage of enterovirus 71 (EV71) vaccine among children born between 2018 and 2021 in Ningbo City, Zhejiang Province, so as to provide insights into formulating EV71 vaccination strategy. Methods Data pertaining to demography and EV71 vaccination among children born between 2018 and 2021 in Ningbo City were obtained from the Zhejiang Immunization Information Management System, and the coverage of vaccination, full-dose vaccination and timely vaccination of EV71 vaccine were analyzed. Results Totally 416 176 children were born between 2018 and 2021, including 216 977 boys (52.14%) and 199 199 girls (47.86%). The coverage rates of vaccination, full-dose vaccination and timely vaccination was 61.50%, 58.70% and 32.53%, respectively. The coverage rates of vaccination, full-dose vaccination and timely vaccination among local children (71.43%, 70.04% and 40.24%) were higher than those among migrant children (54.05%, 50.18% and 26.73%; P<0.05). The coverage rates of vaccination, full-dose vaccination and timely vaccination among urban children (67.72%, 65.06% and 40.37%) were higher than those among rural children (54.11%, 51.14% and 23.21%; P<0.05). The coverage rates of vaccination were 54.98%, 61.24%, 65.10% and 66.72%, the coverage rates of full-dose vaccination were 52.16%, 58.72%, 62.44% and 63.39%, and the coverage rates of timely vaccination were 22.47%, 25.86%, 39.14% and 48.03% by the born year from 2018 to 2021, all showing increasing trends year by year (P<0.05). Conclusions The coverage of vaccination, full-dose vaccination and timely vaccination of EV71 vaccine appears a tendency towards a rise among the 2018-2021 birth cohorts in Ningbo City, while the coverage of timely vaccination need to be improved. Health education for EV71 vaccination should be enhanced for rural and migrant children.
Key wordsenterovirus 71 vaccine    hand,foot and mouth disease    vaccination
收稿日期: 2023-07-10      修回日期: 2023-08-29      出版日期: 2023-10-10
中图分类号:  R725.1  
作者简介: 王炸亚,本科,主管护师,主要从事儿童预防保健、疫苗接种和传染病管理等研究工作
引用本文:   
王炸亚, 叶莉霞, 吴锋. 宁波市2018—2021年出生儿童肠道病毒71型疫苗接种情况分析[J]. 预防医学, 2023, 35(10): 895-898.
WANG Zhaya, YE Lixia, WU Feng. Coverage of enterovirus 71 vaccine among children born between 2018 and 2021 in Ningbo City. Preventive Medicine, 2023, 35(10): 895-898.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.10.014      或      http://www.zjyfyxzz.com/CN/Y2023/V35/I10/895
[1] 中国疾病预防控制中心.肠道病毒71型灭活疫苗使用技术指南[EB/OL].[2023-08-29].https://www.chinacdc.cn/nip/ywdt/zcyj/zcjswj/202112/W020211206570536774575.pdf.
[2] 蒋卓婧,葛小萍,陈金堃,等.绍兴市手足口病病毒型别检测结果分析[J].预防医学,2022,34(5):507-510.
[3] YI E J,SHIN Y J,KIM J H,et al.Enterovirus 71 infection and vaccines[J].Clin Exp Vaccine Res,2017,6(1):4-14.
[4] MAO Q Y,WANG Y,BIAN L,et al.EV71 vaccine,a new tool to control outbreaks of hand,foot and mouth disease(HFMD)[J].Expert Rev Vaccines,2016,15(5):599-606.
[5] HU Y M,WANG X,WANG J Z,et al.Immunogenicity,safety,and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months[J].Clin Vaccine Immunol,2013,20(12):1805-1811.
[6] ZHU F,XU W,XIA J,et al.Efficacy,safety,and immunogenicity of an enterovirus 71 vaccine in China[J].N Engl J Med,2014,370(9):818-828.
[7] ZHU F C,MENG F Y,LI J X,et al.Efficacy,safety,and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China:a multicentre,randomised,double-blind,placebo-controlled,phase 3 trial[J].Lancet,2013,381(9882):2024-2032.
[8] 王凌虹,叶莉霞,顾永权,等.余姚市2012—2018年出生儿童肠道病毒71型疫苗接种分析[J].预防医学,2020,32(9):911-913,916.
[9] 潘伟毅,赵志远,陈俊磊.2017—2018年福建省0~5岁儿童出生队列肠道病毒71型疫苗接种率分析[J].中国生物制品学杂志,2020,33(3):293-296.
[10] 于静,汤奋扬,汪志国,等.江苏省2013—2020年出生队列儿童肠道病毒71型疫苗接种率[J].中国疫苗和免疫,2021,27(5):566-569.
[11] 贾斯月,李靖欣,朱凤才.基于EV71疫苗接种的江苏省手足口病动力学模型研究[J].中华疾病控制杂志,2019,23(3):253-258.
[12] 刘艳,杜渐,王骏,等.杭州市儿童肠道病毒71型灭活疫苗接种特征分析[J].国际流行病学传染病学,2020,47(1):38-41.
[13] 胡瑜超,于伟,鲍伟娜,等.柯桥区1~7岁儿童第二类疫苗接种情况分析[J].预防医学,2019,31(9):927-929.
[14] 刘向东,顾新蕊,冀天娇,等.2013—2015年中国重症手足口病的流行病学特征和病原构成[J].病毒学报,2018,34(4):477-482.
[15] 王丹,李法锦,姚光海,等.贵州省2009—2016年手足口病流行病学特征研究[J].中国疫苗和免疫,2017,23(4):450-454.
[1] 王唐, 董兆鹏, 李淑华, 莫平华, 赵艺明, 宋灿磊. 金山区托幼机构和学校手足口病聚集性疫情分析[J]. 预防医学, 2023, 35(9): 800-802.
[2] 张超, 罗小福, 刘艳, 沈建勇, 徐秦儿, 韩利萍, 马力. 湖州市老年人接种流感灭活疫苗疑似预防接种异常反应监测结果[J]. 预防医学, 2023, 35(8): 701-704.
[3] 钱晓萍, 罗小福, 凌健. 湖州市疫苗接种相关的过敏性皮疹监测结果[J]. 预防医学, 2023, 35(4): 339-341.
[4] 钱晓萍, 凌健, 刘腾. 吴兴区6岁以下儿童手足口病流行特征分析[J]. 预防医学, 2023, 35(3): 243-245,249.
[5] 何飞, 马永法, 顾春艳, 潘铭, 陈万庚. 2005—2021年盐都区水痘流行特征[J]. 预防医学, 2023, 35(1): 61-64.
[6] 江伟, 刘艳, 杜渐, 许玉洋, 车鑫仁, 王婧, 王骏, 张学潮, 顾雯雯, 张小平. 2017—2021年杭州市HPV疫苗疑似预防接种异常反应监测结果[J]. 预防医学, 2023, 35(1): 71-73,77.
[7] 张超, 沈建勇, 罗小福, 徐秦儿, 韩利萍. 2015—2021年湖州市MMR疫苗疑似预防接种异常反应监测结果[J]. 预防医学, 2023, 35(1): 74-77.
[8] 龚震宇, 龚训良. 全球消除脊髓灰质炎进展[J]. 预防医学, 2022, 34(8): 861-862.
[9] 蒋卓婧, 葛小萍, 陈金堃, 王吉玲. 绍兴市手足口病病毒型别检测结果分析[J]. 预防医学, 2022, 34(5): 507-510.
[10] 庞孟涛, 李傅冬, 林君芬, 古雪. 2016—2019年浙江省手足口病流行特征[J]. 预防医学, 2022, 34(3): 307-310.
[11] 吴昊澄, 鲁琴宝, 丁哲渊, 王心怡, 傅天颖, 杨珂, 吴晨, 林君芬. 基于百度指数和手足口病的疱疹性咽峡炎预测模型研究[J]. 预防医学, 2022, 34(3): 217-221.
[12] . 系统性红斑狼疮患者疫苗接种专家共识[J]. 预防医学, 2022, 34(12): 1189-1193.
[13] 王晓柳, 汤元妃. 2018—2021年武义县疑似预防接种异常反应监测结果[J]. 预防医学, 2022, 34(11): 1167-1171,1177.
[14] 孙肖瑜, 郑晓春, 魏晶娇, 陈玲萍, 王志刚, 李万仓, 王婵敏. 2016—2020年温州市流行性乙型脑炎流行特征分析[J]. 预防医学, 2021, 33(9): 919-920.
[15] 林越东, 李峤, 覃青连, 颜星星, 成曼, 周红霞, 唐咸艳. 广西某医学院校女大学生接种HPV 疫苗知识、信念和行为调查[J]. 预防医学, 2021, 33(9): 955-957.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed